Key result
A 25-year review of publications highlights advancements in managing arrhythmic disease in children and adults with congenital heart disease, focusing on devices, ablation, and genomics.
This review highlights 25 years of progress in managing arrhythmias in pediatric and adult congenital heart disease populations.
Answers are grounded in this paper and cite their sources.
May guide arrhythmia management in congenital heart disease; leaves open validation of genomic and device advances in prospective trials.
This review article reflects how publications in EP Europace have contributed to advancing the science of management of arrhythmic disease in children and adult patients with congenital heart disease within the last 25 years. A special focus is directed to congenital atrioventricular (AV) block, the use of pacemakers, cardiac resynchronization therapy devices, and implantable cardioverter defibrillators in the young with and without congenital heart disease, Wolff-Parkinson-White syndrome, mapping and ablation technology, and understanding of cardiac genomics to untangle arrhythmic sudden death in the young.
No takes yet. Share an insight, caveat, or question.
Paul et al. (2023) conducted a review in Arrhythmic disease in children and adult congenital heart disease. Management of arrhythmic disease was evaluated. A 25-year review of publications highlights advancements in managing arrhythmic disease in children and adults with congenital heart disease, focusing on devices, ablation, and genomics.
Synapse has enriched 10 related papers. Consider them for comparative context: